These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3438618)

  • 41. A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity.
    Schröder R; Neuhaus KL; Leizorovicz A; Linderer T; Tebbe U
    J Am Coll Cardiol; 1987 Jan; 9(1):197-203. PubMed ID: 3540072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Group sequential methods for cluster randomization trials with binary outcomes.
    Zou GY; Donner A; Klar N
    Clin Trials; 2005; 2(6):479-87. PubMed ID: 16422308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of a highly purified hyaluronidase preparation (GL enzyme) on electrocardiographic changes in acute myocardial infarction.
    Henderson A; Campbell RW; Julian DG
    Lancet; 1982 Apr; 1(8277):874-6. PubMed ID: 6122100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.
    Hjalmarson A; Elmfeldt D; Herlitz J; Holmberg S; Málek I; Nyberg G; Rydén L; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L; Wilhelmsson C
    Lancet; 1981 Oct; 2(8251):823-7. PubMed ID: 6116950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment and monitoring in clinical trials when survival curves have distinct shapes: a Bayesian approach with Weibull modelling.
    Lecoutre B; Mabika B; Derzko G
    Stat Med; 2002 Mar; 21(5):663-74. PubMed ID: 11870808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of experiments with adaptive interim analyses.
    Bauer P; Köhne K
    Biometrics; 1994 Dec; 50(4):1029-41. PubMed ID: 7786985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
    Kronmal RA
    JAMA; 1985 Apr; 253(14):2091-3. PubMed ID: 3883022
    [No Abstract]   [Full Text] [Related]  

  • 51. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
    Jahn-Eimermacher A; Hommel G
    Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trial of early nifedipine in acute myocardial infarction: the Trent study.
    Wilcox RG; Hampton JR; Banks DC; Birkhead JS; Brooksby IA; Burns-Cox CJ; Hayes MJ; Joy MD; Malcolm AD; Mather HG
    Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1204-8. PubMed ID: 3096431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
    Bénichou J; Lepage E; Chastang C
    Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trial.
    Gottlieb SO; Becker LC; Weiss JL; Shapiro EP; Chandra NC; Flaherty JT; Gottlieb SH; Ouyang P; Mellits ED; Townsend SN
    Br Heart J; 1988 Apr; 59(4):411-8. PubMed ID: 3285878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An acute intervention trial: the research nurse coordinator's role.
    Mullin SM; Warwick S; Akers M; Beecher P; Helminger K; Moses B; Rigby PA; Taplin NE; Werner W; Wettach R
    Control Clin Trials; 1984 Jun; 5(2):141-56. PubMed ID: 6744886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An introduction to the use of interim data analyses in clinical trials.
    Lewis RJ
    Ann Emerg Med; 1993 Sep; 22(9):1463-9. PubMed ID: 8363121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of anticoagulation in acute myocardial infarction.
    Brennan JJ; Cabin HS
    Cardiol Clin; 1988 Feb; 6(1):111-8. PubMed ID: 3048671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current research in statistical methodology for clinical trials.
    Meier P
    Biometrics; 1982 Mar; 38 Suppl():141-53. PubMed ID: 7046819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring versus interim analysis of clinical trials: a perspective from the pharmaceutical industry.
    Enas GG; Dornseif BE; Sampson CB; Rockhold FW; Wuu J
    Control Clin Trials; 1989 Mar; 10(1):57-70. PubMed ID: 2702837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selecting an interim analysis procedure.
    Overall JE; Atlas RS
    Psychopharmacol Bull; 1993; 29(2):141-7. PubMed ID: 8290658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.